The global genomics market size was valued at USD 46.65 billion in 2025 and is projected to grow from USD 52.46 billion in 2026 to USD 134.23 billion by 2034, registering a CAGR of 12.46% during the forecast period from 2026 to 2034. North America dominated the genomics market with a market share of 41.5% in 2025.
Genomics is the branch of biology that studies the complete set of an organism’s genes (genome), including their structure, function, evolution, and interactions. It uses advanced sequencing and bioinformatics technologies to analyze genetic information and identify variations linked to diseases and traits. Genomics plays a vital role in precision medicine, drug discovery, agriculture, biotechnology, and disease prevention by enabling personalized and data-driven healthcare solutions.
Download a Free Sample To learn more about this report,
Expansion of Long-Read and Comprehensive Genome Sequencing
Genomic technology is increasingly moving toward sequencing approaches that can characterize more complex genomic variation and provide broader information from a single analysis. Long-read and whole-genome sequencing can improve the detection and interpretation of structural variants and other genomic features that may be difficult to resolve with narrower testing approaches. This development is expanding the technical capabilities of genomics across research and clinical workflows rather than focusing on AI-enabled interpretation. NHGRI continues to support development of novel sequencing technologies for research and clinical applications.
Increasing Integration of Genomic Data With Clinical Health Information
Genomics is increasingly being connected with clinical records and other health information to make genomic results more usable within routine healthcare workflows. National programs are developing structured data systems, interoperability approaches, and clinical interfaces that allow genomic information to be shared across laboratories, healthcare providers, and patients. This structural change is moving genomics from standalone testing toward integrated clinical information infrastructure.
Expansion of Genomic Testing Across Disease Research and Clinical Care
The genomics market is supported by the expanding use of genomic information across rare diseases, oncology, inherited conditions, pharmacogenomics, and disease-risk assessment. As sequencing becomes more relevant to diagnosis and clinical decision-making, healthcare systems and research organizations have greater incentive to incorporate genomic testing into established care pathways. The growing evidence base for clinical utility is therefore creating demand beyond research-focused sequencing.
High Costs of Genomic Data Infrastructure and Interpretation
The genomics market faces restraints from the substantial infrastructure and expertise required to store, analyze, interpret, and clinically integrate genomic information. Although sequencing costs have fallen considerably, the broader workflow still requires computational resources, variant interpretation, data management, and specialized personnel. These requirements can limit adoption where healthcare organizations lack sufficient genomic infrastructure or trained specialists.
Expansion of Population-Level Genomic Screening
Population-scale genomic screening represents a distinct opportunity for expanding genomics beyond patients already suspected of having genetic disorders. National programs are increasingly evaluating the use of genomic information for screening healthy newborns and adults for inherited disease risks and other clinically actionable conditions. If clinical utility and cost-effectiveness are established, these programs could substantially broaden the addressable population for genomic testing.
Establishing Clinical Utility and Standardized Interpretation of Genomic Results
A major challenge is determining which genomic findings are sufficiently validated to influence clinical decisions. Large sequencing datasets can identify numerous variants whose disease relevance remains uncertain, requiring standardized classification, evidence generation, and expert interpretation before results can be routinely used in care. Differences in clinical workflows, evidence standards, and interpretation practices can therefore slow the translation of genomic discoveries into established medical practice.
Products – Consumables & Reagents Dominated the Market with 39.7% Share in 2025
The products – consumables & reagents segment accounted for the largest share of the global genomics market at 39.7% in 2025, driven by their recurring use in sequencing, PCR, gene expression analysis, and other genomic workflows across research laboratories, clinical diagnostics, and pharmaceutical companies.
Products including systems and software continue to witness steady demand as laboratories invest in advanced genomic platforms and bioinformatics tools. NGS-based services are experiencing rapid adoption with the expansion of precision medicine and large-scale sequencing projects, while core genomics services, biomarker translation services, computational services, and other specialized offerings continue to support genomic research, clinical development, and data analysis.
Request Customizationto receive a tailored report.
Sequencing is Projected to Register the Fastest Growth at a CAGR of 17.4%
The sequencing segment is expected to expand at the highest CAGR of 17.4% during 2026–2034, driven by declining sequencing costs, increasing adoption of next-generation sequencing (NGS), and expanding applications in precision medicine, oncology, and rare disease research.
PCR continues to remain one of the most widely used genomic technologies for gene amplification and molecular diagnostics. Flow cytometry is extensively utilized for cellular analysis and immunology research, while microarrays continue to support gene expression profiling and genotyping applications. Other genomic technologies also contribute to market growth by enabling specialized research and advanced molecular analysis.
Clinical Research Dominated the Market with 31.6% Share in 2025
The clinical research segment accounted for the largest share of the global genomics market at 31.6% in 2025, driven by increasing investments in precision medicine, large-scale genomic studies, biomarker discovery, and clinical trials for personalized therapies.
Pharmaceutical and biotechnology companies continue to be major adopters of genomics technologies for drug discovery, target identification, and companion diagnostics. Academic and government institutes remain at the forefront of genomics research through funding initiatives and collaborative projects, while hospitals and clinics are increasingly integrating genomic testing into routine clinical practice for disease diagnosis, treatment selection, and personalized patient care.
Speak to an Analystto discuss market opportunities.
North America market accounted for 41.5% of the global genomics market, valued at USD 19.36 billion in 2025. The region's growth is driven by increasing investments in genomic research, rising adoption of precision medicine, expanding use of next-generation sequencing technologies, and strong government funding for life sciences research. The presence of leading biotechnology companies and advanced healthcare infrastructure continues to support regional market growth.
The United States market accounted for the largest share of the North American market in 2025. Growth is driven by increasing investments in precision medicine, expanding genomic sequencing applications, rising demand for genetic testing, and the presence of leading biotechnology and pharmaceutical companies. Strong research funding and continuous technological advancements further strengthen the country's market position.
Canada market is witnessing steady market growth due to increasing investments in genomics research, expanding adoption of precision healthcare, rising government support for genetic testing programmes, and growing collaborations between academic institutions and biotechnology companies.
Unlock Regional Insightsto access country-level data, & regional trends.
The European market accounted for 27.4% of the global genomics market, reaching USD 12.78 billion in 2025. Market growth is supported by increasing investments in genomic research, expanding adoption of personalized medicine, rising demand for molecular diagnostics, and growing government initiatives supporting precision healthcare. Continuous advancements in sequencing technologies continue to drive regional demand.
The United Kingdom market is witnessing steady market growth owing to increasing investments in genomic medicine, expanding national genome sequencing initiatives, rising demand for genetic testing, and growing adoption of precision healthcare solutions.
Germany market represents one of the largest markets in Europe, driven by advanced healthcare infrastructure, increasing investments in biotechnology research, expanding use of genomic sequencing technologies, and growing demand for personalized medicine and molecular diagnostics.
Asia Pacific market accounted for 22.6% of the global genomics market, valued at USD 10.54 billion in 2025, and is projected to register the fastest CAGR of 18.4% during the forecast period. The market is expanding due to increasing healthcare expenditure, growing investments in biotechnology research, rising adoption of genomic sequencing, and expanding precision medicine initiatives. Government support for genomics research and improving healthcare infrastructure continue to support regional market growth.
Japan market is witnessing steady market growth due to increasing adoption of genomic sequencing technologies, expanding precision medicine programmes, growing investments in biotechnology research, and continuous advancements in molecular diagnostics.
China market accounted for the largest share of the Asia Pacific market in 2025. Growth is supported by increasing government investments in genomics research, expanding biotechnology capabilities, rising demand for genetic testing, and growing adoption of next-generation sequencing technologies across clinical and research applications.
The Middle East & Africa market represented 3.4% of the global genomics market, totaling USD 1.59 billion in 2025. Rising investments in healthcare infrastructure, expanding genomic research programmes, increasing adoption of precision medicine, and growing demand for advanced molecular diagnostics are supporting regional market growth.
The UAE market is a key market in the Middle East, driven by increasing investments in precision healthcare, expanding national genomic initiatives, growing adoption of advanced genetic testing technologies, and strong government support for biotechnology innovation.
Africa market is witnessing gradual market growth, supported by increasing investments in genomic research, expanding access to molecular diagnostic services, rising collaborations with international research organizations, and growing awareness of precision medicine. Countries such as South Africa, Kenya, and Nigeria are creating long-term growth opportunities for market participants.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Amniotic Membrane Market Size, Share, Growth, Forecast, 2034
Cancer Stem Cell Market Size, Share, Growth, Forecast, 2034
Cell Surface Markers Detection Market Size, Share, Growth, 2034
Blood Testing Market Size, Share, Growth, Analysis, Report, 2034
Cancer Biologics Market Size, Share, Growth, Forecast, 2034
Petri Dishes Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com